Women with bleeding disorders are disproportionately affected by reproductive tract bleeding and other related complications. Data on the management of women with bleeding disorders are hampered by a lack of randomized trials, case control studies or even large case series. In the absence of strong evidence to direct practice, government agencies and hemophilia organizations have developed consensus guidelines. This paper summarizes existing recommendations from these guidelines.